Valuation: Krka, d. d.

Capitalization 7.4B 8.71B 6.83B 6.44B 11.94B 810B 12.15B 80.03B 31.37B 390B 32.67B 31.99B 1,386B P/E ratio 2026 *
18.6x
P/E ratio 2027 * 17.7x
Enterprise value 6.8B 8.01B 6.28B 5.92B 10.98B 745B 11.17B 73.6B 28.85B 359B 30.04B 29.42B 1,275B EV / Sales 2026 *
3.2x
EV / Sales 2027 * 2.99x
Free-Float
70.67%
Yield 2026 *
3.69%
Yield 2027 * 3.78%
1 week+3.39%
Current month+4.72%
1 month+5.17%
3 months+10.41%
6 months+22.31%
Current year+20.20%
1 week 238
Extreme 238
244
1 month 220
Extreme 220
244
Current year 202
Extreme 202
251
1 year 172.5
Extreme 172.5
251
3 years 100
Extreme 100
251
5 years 80
Extreme 80
251
10 years 48.01
Extreme 48.01
251
Manager TitleAgeSince
Chief Executive Officer 70 01/01/2005
Director of Finance/CFO - 01/01/1997
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 59 01/01/2009
Director/Board Member 59 01/01/2005
Director/Board Member 58 01/01/2005
Change 5d. change 1-year change 3-years change Capi.($)
0.00%+3.39%+42.27%+119.82% 8.71B
-1.04%+1.24%-4.34%+67.77% 43.66B
-1.63%-1.13%+54.85%+139.32% 35.47B
-10.00%-3.71%+71.11%+61.87% 9.89B
+0.84%+0.92%-18.11%+36.89% 10.68B
+0.52%+3.12%+13.52%+88.00% 10.16B
-9.01%+0.20%+236.67%+436.09% 7.94B
+0.90%-0.08%+24.42%+61.08% 7.49B
-3.43%-4.10%+40.57%-12.49% 7.36B
0.00%+3.99%+67.57%+358.80% 6.82B
Average -2.29%+0.35%+52.85%+135.72% 14.82B
Weighted average by Cap. -1.88%-0.53%+37.75%+115.54%

Financials

2026 *2027 *
Net sales 2.13B 2.5B 1.96B 1.85B 3.43B 233B 3.49B 23.02B 9.02B 112B 9.4B 9.2B 399B 2.25B 2.65B 2.08B 1.96B 3.63B 246B 3.69B 24.32B 9.53B 118B 9.93B 9.72B 421B
Net income 405M 477M 374M 352M 654M 44.36B 665M 4.38B 1.72B 21.34B 1.79B 1.75B 75.89B 425M 501M 393M 370M 687M 46.59B 698M 4.6B 1.8B 22.41B 1.88B 1.84B 79.69B
Net Debt -594M -700M -549M -517M -959M -65.11B -976M -6.43B -2.52B -31.32B -2.62B -2.57B -111B -670M -788M -618M -583M -1.08B -73.36B -1.1B -7.25B -2.84B -35.29B -2.96B -2.9B -125B
Logo Krka, d. d.
Krka dd Novo Mesto is a Slovenia-based company engaged in the production of pharmaceutical preparations. The Company operates through four segments: Prescription Pharmaceuticals that includes medicines for the treatment of cardiovascular diseases, alimentary tract and metabolism and drugs for diseases of the central nervous system, among others; Non-prescription Products, providing vitamins and minerals, cough and cold products, analgesics, sore throat products, among others; Animal Health Products, which offers general anti-infectives and antiparasitics for animals; Health Resort and Tourist Services consisting of Spa resorts in Smarjeske Toplice, Dolenjske Toplice, Strunjan, Novo Mesto and Otocec. Krka dd Novo Mesto is a controlling company of the Krka Group that includes two subsidiaries in Slovenia, Terme Krka doo and Farma GRS doo, and over 20 subsidiaries abroad in such countries as Croatia, Germany, Sweden, Poland, Spain, United States, Ireland, among others.
Employees
11,667
Date Price Change Volume
16/04/26 244.00 +0.21% 3,900
15/04/26 243.50 +0.62% 3,980
14/04/26 242.00 +1.04% 3,949
13/04/26 239.50 0.00% 4,900
10/04/26 239.50 +1.48% 4,762
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
6
Last Close Price
244.00EUR
Average target price
204.23EUR
Spread / Average Target
-16.30%

Quarterly revenue - Rate of surprise